LAGI, FILIPPO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.238
EU - Europa 2.057
AS - Asia 668
OC - Oceania 40
AF - Africa 21
SA - Sud America 18
Totale 5.042
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.231
RU - Federazione Russa 1.007
IT - Italia 383
PL - Polonia 233
HK - Hong Kong 214
SG - Singapore 201
IE - Irlanda 155
CN - Cina 113
SE - Svezia 113
DE - Germania 45
JO - Giordania 42
AU - Australia 40
FI - Finlandia 39
IN - India 38
ID - Indonesia 30
GB - Regno Unito 26
BR - Brasile 18
ES - Italia 11
CH - Svizzera 10
NL - Olanda 10
KR - Corea 9
CI - Costa d'Avorio 8
RO - Romania 7
VN - Vietnam 7
FR - Francia 6
CA - Canada 5
ET - Etiopia 5
UA - Ucraina 5
KE - Kenya 4
EG - Egitto 2
PK - Pakistan 2
TR - Turchia 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AO - Angola 1
AZ - Azerbaigian 1
CY - Cipro 1
CZ - Repubblica Ceca 1
EE - Estonia 1
HU - Ungheria 1
KZ - Kazakistan 1
LT - Lituania 1
LU - Lussemburgo 1
MA - Marocco 1
MK - Macedonia 1
MX - Messico 1
PA - Panama 1
PH - Filippine 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
Totale 5.042
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.040
Warsaw 232
Hong Kong 163
Dublin 155
Singapore 155
Fairfield 126
Ashburn 118
Chandler 109
Florence 90
Moscow 69
Altamura 50
Lawrence 50
Seattle 41
Melbourne 39
Woodbridge 39
Houston 38
Wilmington 37
Cambridge 34
Helsinki 33
Mumbai 31
Princeton 31
Jakarta 30
Milan 25
Buffalo 22
Kent 21
Rome 20
Boston 18
New York 18
London 16
Shanghai 16
Los Angeles 14
Medford 14
San Diego 14
Ann Arbor 12
West Jordan 12
Beijing 10
Yubileyny 10
Bern 9
Munich 9
Abidjan 8
Dearborn 8
Falkenstein 7
Madrid 7
Seoul 7
Timisoara 7
Dong Ket 6
Pistoia 6
Washington 6
Andover 5
Chicago 5
Guangzhou 5
Naples 5
Nuremberg 5
Pune 5
San Jose 5
Tizzana 5
Warder 5
Arezzo 4
Boardman 4
Bremen 4
Cagliari 4
Camparada 4
Campi Bisenzio 4
Nairobi 4
Prato 4
São Paulo 4
Barcelona 3
Bari 3
Capannori 3
Carugate 3
Catania 3
Cecina 3
Dallas 3
Krefeld 3
Luni 3
Montreal 3
Norwalk 3
Pisa 3
Turin 3
Udine 3
Wuhan 3
Amman 2
Ansan-si 2
Campobasso 2
Chengdu 2
Chieti 2
Colle di Val d'Elsa 2
Cortona 2
Falls Church 2
Hangzhou 2
Hillsboro 2
Hounslow 2
Jinan 2
Kaohsiung City 2
Leeds 2
Livorno 2
L’Aquila 2
Modena 2
Mykolayiv 2
Nanjing 2
Totale 3.196
Salva come PNG Salva come JPEG
Nome #
Proposal for a New Score-Based Approach To Improve Efficiency of Diagnostic Laboratory Workflow for Acute Bacterial Meningitis in Adults 359
Imported dengue fever in Tuscany, Italy, in the period 2006 to 2012. 170
Results of comprehensive cardiovascular diagnostic work-up in HIV positive patients 120
Early discharge criteria in patients with acute bacterial skin and skin structure infections in a large tertiary-care teaching hospital in Florence, Italy 119
Arbo-score: A rapid score for early identification of patients with imported arbovirosis caused by Dengue, Chikungunya and zika virus 114
Cancer population may be paradoxically protected from severe manifestations of COVID-19 113
Reply: COVID-19: Semen impairment may not be related to the virus 107
Tubercular prosthetic joint infection: two case reports and literature review 106
Male reproductive system inflammation after healing from coronavirus disease 2019 102
Seasonal Allergic Rhinitis Symptoms in Relation to COVID-19 101
Prompt Predicting of Early Clinical Deterioration of Moderate-to-Severe COVID-19 Patients: Usefulness of a Combined Score Using IL-6 in a Preliminary Study 98
Use of the FebriDx point-of-care test for the exclusion of SARS-CoV-2 diagnosis in a population with acute respiratory infection during the second (COVID-19) wave in Italy 96
Continuum of care among HIV-1 positive patients in a single center in Italy (2007–2017) 94
Long-term maintenance of virologic suppression in native and migrant HIV-1 naïve patients: an Italian cohort study 94
First-dose mRNA vaccination is sufficient to reactivate immunological memory to SARS-CoV-2 in subjects who have recovered from COVID-19 93
Leptospirosis acquired by tourists in Venice, Italy 91
The prognostic role of IL-10 in non-severe COVID-19 with chemosensory dysfunction 91
Diagnostic accuracy of physician’s gestalt in suspected COVID-19: Prospective bicentric study 87
Can SSRI/SNRI antidepressants decrease the 'cytokine storm' in the course of COVID-19 pneumonia? 86
Prevalence and Correlates of Sexually Transmitted Infections in Transgender People: An Italian Multicentric Cross-Sectional Study 85
Risk factors for extended-spectrum beta-lactamase-producing Enterobacteriales infection: are they the same in neutropenic and non-neutropenic patients? 85
Procalcitonin for the differential diagnosis of COVID-19 in the emergency department. Prospective monocentric study 83
Implementing Early Phase Treatments for COVID-19 in Outpatient Settings: Challenges at a Tertiary Care Center in Italy and Future Outlooks 81
Early experience of an infectious and tropical diseases unit during the coronavirus disease (COVID-19) pandemic, Florence, Italy, February to March 2020 81
Clinical role of viral identification by a polymerase chain reaction-based diagnostic panel in adults hospitalized with community-acquired pneumonia 81
Imported dengue fever in Tuscany, Italy, in the period 2006 to 2012. 81
Efficacy and safety of Pentamidine isethionate for tegumentary and visceral human leishmaniasis: a systematic review 81
Early discontinuation of DTG/ABC/3TC and BIC/TAF/FTC single-tablet regimens: a real-life multicenter cohort study 80
SARS-CoV-2 infection and vaccination trigger long-lived B and CD4+ T lymphocytes: implications for booster strategies 79
DYNAMIC OF TRANSMISSION AND ACQUISITION OF HIV AMONG MIGRANTS FROM PERU LIVING IN FLORENCE: IMPLICATIONS FOR EFFECTIVELY MANAGING HIV PREVENTION AND RETENTION PROGRAMMES 77
Prospective study on incidence, risk factors and outcome of recurrent clostridioides difficile infections 77
High-dose steroids for the treatment of severe COVID-19 74
Comparison of the efficacy, safety and durability of a switch to co-formulated RPV/TDF-TAF/FTC or DTG/ABC/3TC in virologically-suppressed HIV-1-infected patients in a single Italian centre: a cohort data analysis 74
Treatment with anti-SARS-CoV-2 monoclonal antibodies in pregnant and postpartum women: first experiences in Florence, Italy 73
The never-ending story of mpox epidemic: Tracing a new cluster in Florence, Italy 72
Safety and Efficacy of Outpatient Treatments for COVID-19: Real-Life Data from a Regionwide Cohort of High-Risk Patients in Tuscany, Italy (the FEDERATE Cohort) 72
Latent Tuberculosis Infection and COVID-19: Analysis of a Cohort of Patients from Careggi University Hospital (Florence, Italy) 69
Facilitators and barriers in HIV testing and continuum of care among migrant transgender women who are sex workers residing in Florence, Italy 69
Effects of viremia and CD4 recovery on gut "microbiome-immunity" axis in treatment-naïve HIV-1-infected patients undergoing antiretroviral therapy 65
When it rains, it pours: Early treatment with tecovirimat of cardiac complications associated with monkeypox infection in a person with HIV and previously undiagnosed Lyme disease. A case report 64
Fourth Dose of mRNA COVID-19 Vaccine Transiently Reactivates Spike-Specific Immunological Memory in People Living with HIV (PLWH) 59
Characteristics of COVID-19 vaccinated and unvaccinated patients admitted to Careggi University Hospital, Florence, Italy 58
Monkeypox: A novel pitfall in clinical dermatology 58
Antibodies Induced by Smallpox Vaccination after at Least 45 Years Cross-React with and In Vitro Neutralize Mpox Virus: A Role for Polyclonal B Cell Activation? 57
A comparison between two dolutegravir-based two-drug regimens as switch strategies in a multicentre cohort of HIV-1-infected patients 56
Cefiderocol use for the treatment of infections by carbapenem-resistant Gram-negative bacteria: an Italian multicentre real-life experience 54
Semen impairment and occurrence of SARS-CoV-2 virus in semen after recovery from COVID-19 53
Use of colistin in adult patients: A cross-sectional study 51
Oral microbiota signatures associated with viremia and CD4 recovery in treatment-naïve HIV-1-infected patients 49
Efficacy and durability of two- vs. three-drug integrase inhibitor-based regimens in virologically suppressed HIV-infected patients: Data from real-life ODOACRE cohort 49
Prevalence and determinants of resistance mutations in HIV-1-infected patients exposed to integrase inhibitors in a large Italian cohort 45
Use of next-generation sequencing on HIV-1 DNA to assess archived resistance in highly treatment-experienced people with multidrug-resistant HIV under virological control: data from the PRESTIGIO Registry 44
Impact of rapid-antiretroviral therapy in a cohort of treatment-naïve migrants living with HIV in a high income setting 43
Emergence of dengue fever: sentinel travellers uncover outbreak in Sharm El-Sheikh, Egypt, May 2024 42
Polypharmacy, anticholinergic burden and drug–drug interaction assessment in people with four-class-resistant HIV: data from the PRESTIGIO registry 40
The burden of clostridioides difficile infection during the COVID-19 pandemic: A retrospective case-control study in Italian hospitals (CloVid) 39
Cohort profile: The Observational cohort for the study of DOlutegravir in Antiretroviral Combination REgimens (ODOACRE) 38
Overall Tolerability of Integrase Inhibitors in Clinical Practice: Results from a Multicenter Italian Cohort 38
Analysing the efficacy and tolerability of dolutegravir plus either rilpivirine or lamivudine in a multicentre cohort of virologically suppressed PLWHIV 38
Transgender people living with HIV: characteristics and comparison to homosexual and heterosexual cisgender patients in two Italian teaching hospitals 37
Has COVID-19 changed the approach to HIV diagnosis?: A multicentric Italian experience 36
Efficacy and Durability of Dolutegravir- or Darunavir-Based Regimens in ART-Naïve AIDS- or Late-Presenting HIV-Infected Patients 36
Malattie Tropicali Neglette in un'area non endemica, la casistica del Centro di Riferimento della Regione Toscana per lo Studio e la Cura delle Malattie Tropicali (1999-2013) 36
Babesiosis in the immunocompromised population: Results from a multicentric cohort study conducted in Italy 34
Real-Life Impact of Drug Toxicity on Dolutegravir Tolerability: Clinical Practice Data from a Multicenter Italian Cohort 31
Incidence of hypoglycaemia associated with transient loss of consciousness. A retrospective cohort study 29
Efficacy and safety of switching to dolutegravir plus emtricitabine/tenofovir disoproxil fumarate (TDF) or elvitegravir/cobicistat/emtricitabine/TDF in virologically suppressed HIV-infected patients in clinical practice: results from a multicentre, observational study 29
Viro-immunological efficacy and tolerability of dolutegravir-based regimens compared to regimens based on other integrase strand inhibitors, protease inhibitors or non-nucleoside reverse transcriptase inhibitors in patients with acute HIV-1 infection: A multicenter retrospective cohort study 28
VIRO-immunological response of drug-naive HIV-1-infected patients starting a first-line regimen with viraemia >500,000 copies/ml in clinical practice 27
Efficacy and safety of dolutegravir-based regimens in advanced HIV-infected naïve patients: results from a multicenter cohort study 23
Single tablet regimen with abacavir/lamivudine/dolutegravir compared with two-drug regimen with lamivudine and dolutegravir as different strategies of simplification from a multicenter HIV cohort study 23
Semen impairment and occurrence of SARS-CoV-2 virus in semen after recovery from COVID-19 4
Totale 5.128
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.939
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.939
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202081 0 0 0 0 0 0 0 26 24 13 15 3
2020/2021243 9 14 2 31 34 31 8 15 31 17 15 36
2021/2022229 10 17 13 10 4 24 4 28 5 13 32 69
2022/2023723 45 151 44 20 26 120 100 43 88 13 53 20
2023/2024687 21 41 68 30 46 88 21 170 24 99 52 27
2024/20252.856 130 356 217 627 934 440 118 34 0 0 0 0
Totale 5.128